Detalles de la búsqueda
1.
Body-Weight Fluctuations and Outcomes in Coronary Disease.
N Engl J Med
; 376(14): 1332-1340, 2017 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28379800
2.
Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial.
Eur Heart J
; 35(27): 1801-8, 2014 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23990605
3.
Systemic exposure to atorvastatin between Asian and Caucasian subjects: a combined analysis of 22 studies.
Am J Ther
; 19(3): 164-73, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20975528
4.
An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia.
Pediatr Cardiol
; 32(4): 433-41, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21259004
5.
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial.
J Am Coll Cardiol
; 75(17): 2110-2118, 2020 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32194196
6.
Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
J Clin Lipidol
; 12(2): 356-366, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29310989
7.
Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis.
Clin Drug Investig
; 37(8): 775-785, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28573499
8.
Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack.
J Am Coll Cardiol
; 69(2): 147-158, 2017 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28081824
9.
Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial.
Am J Cardiol
; 119(3): 379-387, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27939230
10.
Safety of atorvastatin in Asian patients within clinical trials.
Cardiovasc Ther
; 34(6): 431-440, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27520479
11.
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?
Am J Med
; 129(4): 384-91, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26551986
12.
Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study).
Am J Cardiol
; 118(4): 494-8, 2016 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27328952
13.
Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.
Drugs Aging
; 32(12): 1055-65, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26625880
14.
Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.
J Am Coll Cardiol
; 65(13): 1286-1295, 2015 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25835440
15.
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.
Heart
; 101(5): 356-62, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25595417
16.
Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.
Am J Cardiol
; 115(4): 447-53, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25637322
17.
Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
Am J Med
; 127(1): 71-81.e1, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24210549
18.
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.
Am J Cardiol
; 113(12): 2018-20, 2014 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24793673
19.
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels.
Int J Cardiol
; 168(4): 3846-52, 2013 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-24001698
20.
Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL.
J Am Coll Cardiol
; 65(4): 402-404, 2015 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25634843